Novartis agreed and resolved to widespread FCPA offenses

Novartis agreed and resolved to widespread FCPA offenses

Resolución y antecedentes del caso Novartis.

Pharmaceutical giant Novartis AG and two subsidiaries (one current and one former) agreed Thursday to pay the DOJ and SEC $346.7 million in penalties and disgorgement to resolve FCPA offenses in Greece, Vietnam, and South Korea.

In the Matter of NOVARTIS AG, Respondent (ORDER INSTITUTING CEASE-ANDDESIST PROCEEDINGS PURSUANT TO SECTION 21C OF THE SECURITIES EXCHANGE ACT OF 1934, MAKING FINDINGS, AND IMPOSING A CEASEAND-DESIST ORDER)

(SECURITIES EXCHANGE ACT OF 1934 Release No. 77431 / March 23, 2016 - ACCOUNTING AND AUDITING ENFORCEMENT. Release No. 3759 / March 23, 2016)

In the Matter of NOVARTIS AG Respondent. (ORDER INSTITUTING CEASE-AND-DESIST PROCEEDINGS PURSUANT TO SECTION 21C OF THE SECURITIES EXCHANGE ACT OF 1934, MAKING FINDINGS, AND IMPOSING A CEASE-AND-DESIST ORDER)

(SECURITIES EXCHANGE ACT OF 1934. Release No. 89149 / June 25, 2020, ACCOUNTING AND AUDITING ENFORCEMENT. Release No. 4150 / June 25, 2020)

CASE NO. 20-cr-538 - UNITED STATES OF AMERICA v. NOVARTIS HELLAS S.A.C.I. Defendant.

UNITED STATES OF AMERICA v. NOVARTIS HELLAS S.A.C.I

Citar: elDial.com - CC6704

Copyright 2024 - elDial.com - editorial albrematica - Tucumán 1440 (1050) - Ciudad Autónoma de Buenos Aires - Argentina